Charles River Laboratories International Investor Presentation
Charles River Laboratories is hosting its 2026 Investor Day to unveil its 'Pathway to Purpose' strategic vision, which aims to modernize operations and generate over $300 million in cumulative savings through 2030. The company reaffirmed its 2026 guidance at the upper end of prior ranges and introduced long-term targets including a 5-7% organic revenue CAGR and a ~24% non-GAAP operating margin by 2030.
- Term
- through 2030